Core Medical Technology Funding: $29M Raised, Series D
Core Medical Technology is based in Shenzhen, China. It has raised $29M in total funding. Latest round: Series D.
Core Medical Technology funding overview
Core Medical Technology is based in Shenzhen, China. Core Medical Technology has raised $29M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in April 2023. The round record for Core Medical Technology runs through 2023; nothing later has been disclosed. Investors on record include Loyal Valley Capital, New Alliance Capital, Shenzhen Salubris Pharmaceuticals, Nanshan War Xintou, Hillhouse Investment, Co-Stone Venture Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
Core Medical Technology at a glance
Total raised
$29M
Latest round
Series D
Latest round date
April 2023
Headquarters
Shenzhen, China
Notable investors
Loyal Valley Capital, New Alliance Capital, Shenzhen Salubris Pharmaceuticals, Nanshan War Xintou, Hillhouse Investment, Co-Stone Venture Capital, Beihang Investment
Frequently asked about Core Medical Technology funding
How much has Core Medical Technology raised?
Core Medical Technology has raised $29M in total disclosed funding across the rounds on record.
Who has invested in Core Medical Technology?
Loyal Valley Capital, New Alliance Capital, Shenzhen Salubris Pharmaceuticals, Nanshan War Xintou, Hillhouse Investment, Co-Stone Venture Capital are named among the investors backing Core Medical Technology.
What was the latest Core Medical Technology funding round?
The most recent disclosed round is a Series D, announced in April 2023.
Where is Core Medical Technology based?
Core Medical Technology is based in Shenzhen, China.
When did Core Medical Technology last raise?
The last disclosed Core Medical Technology round closed in April 2023 at Series D.
Totals shown for Core Medical Technology aggregate every disclosed round on file. To see how that compares, browse the companies in Shenzhen and the investors behind them below.